Aemetis, Inc. Reports Third Quarter 2015 Financial Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Aemetis, Inc. Reports Third Quarter 2015 Financial Results

CUPERTINO, CA--(Marketwired - Nov 5, 2015) - Aemetis, Inc. ( NASDAQ : AMTX ), an advanced renewable fuels and renewable chemicals company, today announced its financial results for the three and nine months ended September 30, 2015.

"Our India biodiesel revenues grew 56% sequentially quarter over quarter through the development of a sustainable domestic customer base, which was made possible by key government policy changes earlier in the year. On October 21, 2015, the Indian Government removed a key tax barrier for the production of biodiesel, enabling Aemetis to source feedstock worldwide and expand our business in India much more rapidly," stated Eric McAfee, Chairman and CEO of Aemetis. "Our US ethanol business is showing steady signs of improvement driven by increased demand, but low prices caused by excess supply due to the two year delay by the EPA in establishing the Renewable Fuel Standard mandate."

"Importantly, we received an additional $2.0 million of EB-5 subordinated debt funding during the third quarter, totaling $23.5 million of funding released to Aemetis. As of September 30, 2015, our escrow account holds an additional $11.5 million of EB-5 funding. With one investor approved for funding and one investor identified for the last available unit, the offering is nearly complete. This 3% interest rate funding will be used to redeem higher rate senior debt," said McAfee.

Financial Results for the Three Months Ended September 30, 2015

Revenues were $38.5 million for the third quarter of 2015, compared to $48.3 million for the third quarter of 2014. Decreases in ethanol and wet distiller's grain average selling prices and volumes resulted in revenue declining during the third quarter as compared to the same period of the prior year. Gross profit for the third quarter of 2015 was $1.0 million, compared to $7.7 million in the third quarter of 2014. During this period, ethanol and wet distiller's grain pricing fell more rapidly than feedstock purchase costs.

Selling, general and administrative expenses were $2.8 million in the third quarter of 2015, compared to $3.0 million in the third quarter of 2014. The decrease in selling, general and administrative expenses was driven by improved efficiencies and lower spending compared to the same period of the prior year.

Operating loss was $1.9 million for the third quarter of 2015, compared to operating income of $4.6 million for the same period in 2014.

Net loss was $5.8 million for the third quarter of 2015, compared to net income of $0.5 million for the third quarter of 2014.

Adjusted EBITDA for the third quarter of 2015 was a loss of $0.5 million, compared to Adjusted EBITDA of $6.1 million for the same period in 2014.

Cash at the end of the third quarter of $2.5 million compared favorably to $0.3 million at the close of 2014.

During the third quarter of 2015, the EB-5 program provided $2.0 million of low-cost debt funding. Interest costs during the third quarter of 2015 were $3.9 million, compared to interest cost of $4.3 million during the third quarter of 2014.

Financial Results for the Nine Months Ended September 30, 2015

Revenues were $111.3 million for the nine months of 2015, compared to $166.2 million for nine months of 2014. Decreases in ethanol and wet distiller's grain average selling prices and volumes in the nine months of 2015 compared to same period in 2014 resulted in revenue declining for the first nine months of 2015. Gross profit for the nine months of 2015 was $2.8 million, compared to $34.7 million during the same period in 2014. During this period, ethanol and wet distiller's grain pricing fell more rapidly than feedstock purchase costs.

Selling, general and administrative expenses were $9.6 million during the nine months of 2015, compared to $9.3 million during the nine months of 2014. The increase in selling, general and administrative expenses was primarily attributable to financial advisory fees.

Operating loss was $7.1 million for the nine months of 2015, compared to operating income of $25.1 million for the same period in 2014.

Net loss was $20.7 million for the nine months of 2015, compared to net income of $10.9 million for the same period in 2014.

Adjusted EBITDA for the nine months of 2015 was loss of $3.0 million, compared to Adjusted EBITDA of $29.4 million for the same period in 2014.

During the nine months of 2015, the EB-5 program provided $22.0 million of low-cost EB-5 debt funding. Interest costs during the nine months of 2015 were $13.4 million, compared to $14.4 during the nine months of 2014 due to the lower cost of EB-5 funds in the capitalization structure.

About Aemetis

Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and renewable chemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of second-generation ethanol and biodiesel plants into advanced biorefineries. Founded in 2006, Aemetis owns and operates a 60 million gallon per year ethanol production facility in the California Central Valley near Modesto. Aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India and Europe. Aemetis operates a research and development laboratory at the Maryland Biotech Center, and holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com .

NON-GAAP FINANCIAL INFORMATION

We have provided non-GAAP measures as a supplement to financial results based on GAAP. A reconciliation of the non-GAAP measures to the most directly comparable GAAP measures is included in the accompanying supplemental data. Adjusted EBITDA is defined as net income/(loss) plus (to the extent deducted in calculating such net income) interest and amortization (income)/expense, depreciation expense, income/(expense) from share-based compensation and (gains)/losses resulting from debt extinguishment.

Adjusted EBITDA is not calculated in accordance with GAAP and should not be considered as an alternative to net income/(loss), operating income or any other performance measures derived in accordance with GAAP or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA is presented solely as a supplemental disclosure because management believes that it is a useful performance measure that is widely used within the industry in which we operate. In addition, management uses Adjusted EBITDA for reviewing financial results and for budgeting and planning purposes. EBITDA measures are not calculated in the same manner by all companies and, accordingly, may not be an appropriate measure for comparison.

Safe Harbor Statement

This news release contains forward-looking statements, including statements regarding our assumptions, projections, expectations, targets, intentions or beliefs about future events or other statements that are not historical facts. Forward-looking statements in this news release include, without limitation, expectations for growth in India, the impact that the recent regulatory changes in India will have on our business expectations for uses of EB-5 funding and expectations for receipt of additional EB-5 funding. Words or phrases such as "anticipates," "may," "will," "should," "believes," "estimates," "expects," "intends," "plans," "predicts," "projects," "targets," "will likely result," "will continue" or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on current assumptions and predictions and are subject to numerous risks and uncertainties. Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions due to certain factors, including, without limitation, competition in the ethanol and other industries in which we operate, commodity market risks including those that may result from current weather conditions, financial market risks, customer adoption, counter-party risks, risks associated with changes to federal policy or regulation, and other risks detailed in our reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2014, our Quarterly Report on Form 10-Q for the quarter ended September 30, 2015 and in our subsequent filings with the SEC. We are not obligated, and do not intend, to update any of these forward-looking statements at any time unless an update is required by applicable securities laws.

                         
AEMETIS, INC.              
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS         
(unaudited, in thousands except per share data)            
   
    For the three months ended Sept. 30,     For the nine months ended Sept. 30,  
(in thousands, except per share)   2015     2014     2015     2014  
Revenues   $ 38,510     $ 48,348     $ 111,303     $ 166,208  
Cost of goods sold     37,476       40,633       108,548       131,516  
Gross profit     1,034       7,715       2,755       34,692  
                                 
Research and development expenses     117       101       330       342  
Selling, general and administrative expenses     2,774       2,972       9,556       9,263  
Operating income/(loss)     (1,857 )     4,642       (7,131 )     25,087  
                                 
Interest rate expense     (2,610 )     (2,287 )     (7,641 )     (7,737 )
Amortization expense     (1,258 )     (741 )     (5,386 )     (5,361 )
Loss on debt extinguishment     -       (1,231 )     (330 )     (1,346 )
Loss on sale or disposal of assets     -       -       -       (119 )
Other income/(expense)     (30 )     81       (191 )     355  
                                 
Income/(loss) before income taxes     (5,755 )     464       (20,679 )     10,879  
                                 
Income tax expense     -       -       (6 )     (6 )
                                 
Net income/(loss)   $ (5,755 )   $ 464     $ (20,685 )   $ 10,873  
                                 
Net Income/(loss) per common share*                                
  Basic   $ (0.29 )   $ 0.02     $ (1.04 )   $ 0.54  
  Diluted   $ (0.29 )   $ 0.02     $ (1.04 )   $ 0.52  
                                 
Weighted average shares outstanding*                                
  Basic     19,521       20,555       19,898       20,284  
  Diluted     19,521       21,476       19,898       20,946  
                                   
* The Earnings per share and Weighted average shares outstanding for all periods presented reflect the one-for-ten reverse split, which took effect May 15, 2014.
 
 
             
AEMETIS, INC.            
CONSOLIDATED CONDENSED BALANCE SHEETS            
(unaudited, in thousands)            
             
    September 30, 2015     December 31, 2014  
Assets                
Current assets:                
  Cash and cash equivalents   $ 2,516     $ 332  
  Accounts receivable     2,229       1,262  
  Inventories     3,771       4,491  
  Prepaid expenses and Other current assets     1,044       1,848  
Total current assets     9,560       7,933  
                 
Property, plant and equipment, Net     71,934       75,810  
Goodwill, Intangibles and Other assets     5,473       5,433  
Total assets   $ 86,967     $ 89,176  
                 
Liabilities and stockholders' equity/(deficit)                
Current liabilities:                
  Accounts payable     7,725       8,339  
  Current portion of long term debt, notes and working capital     5,555       6,032  
  Short term borrowings     7,075       6,714  
  Mandatorily redeemable Series B convertible preferred stock     2,716       2,641  
  Other current liabilities     4,048       3,590  
Total current liabilities     27,119       27,316  
                 
Long term liabilities                
  Senior secured notes     59,558       57,648  
  EB-5 notes     23,500       1,534  
  Other long term liabilities     5,818       5,650  
                 
Stockholders' deficit     (29,028 )     (2,972 )
                 
Total liabilities and stockholders' equity/(deficit)   $ 86,967     $ 89,176  
                 
                 
 
RECONCILIATION OF ADJUSTED EBITDA TO NET INCOME/(LOSS)
(unaudited, in thousands)
         
    For the three months ended Sept. 30,   For the nine months ended Sept. 30,
    2015     2014   2015     2014
Net income/(loss)   $ (5,755 )   $ 464   $ (20,685 )   $ 10,873
Adjustments:                            
  Interest rate expense     2,610       2,287     7,641       7,737
  Amortization expense     1,258       741     5,386       5,361
  Loss on debt extinguishment     -       1,231     330       1,346
  Income tax expense     -       -     6       6
  Intangibles and other amortization expense     32       31     96       95
  Depreciation expense     1,172       1,184     3,560       3,486
  Share-based compensation     161       157     694       447
Total adjustments     5,233       5,631     17,713       18,478
Adjusted EBITDA   $ (522 )   $ 6,095   $ (2,972 )   $ 29,351
                             
                             
 
PRODUCTION AND PRICE PERFORMANCE
(unaudited)
         
    For the three months ended Sept. 30,   For the nine months ended Sept. 30,
    2015   2014   2015   2014
Ethanol                        
Gallons Sold (in millions)     14.2     14.7     42.6     45.7
Average Sales Price/Gallon   $ 1.76   $ 2.29   $ 1.74   $ 2.65
                         
WDG                        
Tons Sold (in thousands)     88.6     96.0     275.9     310.4
Average Sales Price/Ton   $ 75   $ 85   $ 82   $ 100
                         
Biodiesel                        
Metric tons sold (in thousands)     7.6     3.8     12.1     7.6
Average Sales Price/Metric ton   $ 685   $ 992   $ 734   $ 1,003
                         
Refined Glycerin                        
Metric tons sold (in thousands)     1.2     0.7     4.0     1.6
Average Sales Price/Metric ton   $ 714   $ 932   $ 667   $ 997
                         
                         

Company, Investor Relations & Media Contact: Satya Chillara (408) 213-0939 schillara@aemetis.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 112

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 94

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Fraud0-FouAnalytics Takes Aim at Legacy Ad Verification

Updated Category News Views 160

Digital ad measurement has spent years grading its own homework, and that little arrangement may finally be getting some daylight. fraud0 and FouAnalytics say their expanded partnership will give advertisers impression-level visibility into where ads actually rendered, whether apparent humans engaged with them, and where wasted Google Ads spend might be recoverable. The...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 135

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 157

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 142

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 118

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 111

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 97

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 94

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading

Top 5 Most Recently Viewed Articles

Health-Ade Partners with Wheel of Fortune and Ryan Seacrest

Updated Category News Views 212

Health-Ade Shines at Wheel of Fortune Premiere Health-Ade is thrilled to announce its prominent involvement in the premiere week of the classic game show, Wheel of Fortune, as it embarks on an exciting new journey with Ryan Seacrest as the show's host. This is an exhilarating moment not only for Wheel of Fortune but also for Health-Ade Kombucha, which is celebrated for...

Continue Reading
Investment Fund Trends and Insights for October 2024

Updated Category News Views 101

Mutual Fund and ETF Asset Management In the scope of mutual funds and exchange-traded funds (ETFs), the latest insights reveal a steady growth in assets and sales throughout the investment landscape. As investors look for diverse options, investment funds have shown resilience and dynamic adaptability, showcasing robust growth metrics in their respective categories....

Continue Reading
S&P and Pantera Take Digital Asset Indexing to New Heights

Updated Category News Views 18

Digital Assets: A New Benchmark in Town Date it, folks: July 21, 2026. S&P Dow Jones Indices and Pantera Capital are rolling out a fresh digital asset index. They're slapping the 'S&P Pantera' name on something focused less on the casino vibe you get from memes and Bitcoin mania, and more on actual economic value and real-world use. Flipping the script on the way most of...

Continue Reading
Gundry MD Wins Big with Innovative Softgel Formula

Updated Category News Views 57

Breaking New Ground in Weight Management Forget the caffeine-laden pills and appetite-killer potions—here comes something that simply whispers to your gut and says, "Manage your weight naturally." That's what Gundry MD's Daily Weight Advantage™ has cooked up, bagging the prestigious NutraIngredients-USA's Weight Management Product of 2026 award. Finally, a product...

Continue Reading
Ciena's Options Market Insights: Bullish Trends and Growth Prospects

Updated Category News Views 202

Understanding Ciena's Recent Options Activity Investors with significant resources have shown a clear bullish sentiment towards Ciena (NYSE: CIEN), indicating crucial trends that market observers should consider. By monitoring options records, it’s clear that substantial movements are occurring within the CIEN stock, hinting that noteworthy developments might be on the...

Continue Reading